You are here


New research includes communicating with women during PrEP clinical trials

October 15, 2019

Dr. Timothy Mastro, Chief Science Officer at FHI 360, highlights recent articles from FHI 360’s published research. In this group are articles on intimate partner violence and contraceptive use in Nepal, the long‐term impact of Ebola virus disease among women following an acute infection, and communication strategies to reach women at-risk for HIV infection in pre-exposure prophylaxis (PrEP) clinical trials.

For the full list of highlighted articles, books or book chapters authored by FHI 360 experts, read the latest recently published research.

Listen to Dr. Mastro’s previous top picks: